Mydecine Innovations Group Closes Debt Settlements

Core Points - Mydecine Innovations Group Inc. has successfully closed debt settlement agreements totaling USD $1,386,391 and CAD $9,432,107 to settle outstanding debts with various creditors [1][2] - The company issued five convertible debentures to creditors as part of the debt settlements to preserve cash for working capital and improve its financial situation [2] Debt Settlement Agreements - The company entered into debt forgiveness agreements to settle USD $1,386,391 owed to two former insiders, issuing convertible debentures with an aggregate principal amount of USD $100,000 [4] - A debt settlement agreement with CEO Josh Bartch was made to settle CAD $1,309,836 of unpaid management fees, with a convertible debenture issued for the same amount [5] - A settlement with Pioneer Garage Limited was made for CAD $7,878,792, with a convertible debenture issued under similar terms as the Bartch agreement [6] - An additional settlement with an arm's length creditor for CAD $243,479 was fully settled through a secured convertible debenture of USD $100,000, which bears interest at 1% per month [9] Share Consolidation - The company announced a share consolidation effective October 21, 2025, converting every fifty old common shares into one new common share, reducing the outstanding shares from 61,755,385 to approximately 1,235,107 [12][13] - The share consolidation aims to enhance the company's attractiveness for financing opportunities and facilitate the restructuring of existing liabilities [15]